Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
In Cancer
100%
Alternative Splicing
100%
Oncogenesis
100%
Drug Resistance
100%
Splicing Factor
40%
Spliceosome
40%
Aberrant Splicing
40%
Anti-cancer Drug Treatment
40%
Pre-mRNA
40%
Tumor
20%
Cancer Cells
20%
Therapeutic Agents
20%
Synergistic Effect
20%
Aberrations
20%
Relevant Genes
20%
Molecular Mechanism
20%
C-Myc
20%
Evade
20%
Novel Treatments
20%
Cancer Model
20%
Healthy Tissue
20%
Protein-coding Genes
20%
Cancer-related
20%
Cancer Progression
20%
Vulnerability
20%
Healthy Cells
20%
Prognostic Biomarker
20%
Cell Surface Display
20%
Wide Detection
20%
Metabolism
20%
CD19
20%
Sequencing Studies
20%
Functional Relevance
20%
Chromatin Modifiers
20%
Malignant Cells
20%
Differential Expression
20%
Small Molecule Inhibitors
20%
Drug Uptake
20%
Therapeutic Window
20%
Resistant Cells
20%
Splicing Modulator
20%
Myeloid Cell leukemia-1 (Mcl-1)
20%
Oncogenic Transformation
20%
Antitumor Agents
20%
RNA Modification
20%
Resistance to Therapy
20%
Multiple Cancer Types
20%
SF3B1
20%
Apoptosis Regulation
20%
Cancer Pathogenesis
20%
Detection Method
20%
Nuclear Receptor
20%
Clinical Reports
20%
Response to Immunotherapy
20%
High Complexity
20%
High Diversity
20%
Splicing Alteration
20%
Prediction Method
20%
Treatment Opportunity
20%
Whole Transcriptome
20%
Splicing Regulator
20%
Plethora
20%
Transcriptome Sequencing
20%
Regulatory Sequence
20%
Bcl-x
20%
Anticancer Drug Resistance
20%
Splice Factor Kinases
20%
Non-coding Sequence
20%
Chromatin Status
20%
Splicing Regulation
20%
Decreased Toxicity
20%
SLC29A1
20%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
Alternative Splicing
100%
Drug Resistance
100%
Splicing Factor
40%
Anticancer
40%
Spliceosome
40%
Precursor mRNA
40%
Cancer Cell
20%
Small Molecule
20%
Preclinical Study
20%
Metabolic Pathway
20%
RNA Sequencing
20%
MCL1
20%
Regulatory Sequence
20%
Low Drug Dose
20%
SF3B1
20%
Nuclear Receptor
20%
Drug Uptake
20%
CD19
20%
Messenger RNA
20%